Volpara Health Technologies will feature its latest software for breast density, evaluating cancer risk, and mammography quality with Lunit's Insight AI software for early cancer detection at the 2024 National Consortium of Breast Centers (NCBC) conference in Las Vegas.
During a special session on Tuesday, March 19, Tami Hudson, breast health navigator at Singing River Health System in Mississippi will share the clinical impact of making cancer risk assessment standard for every patient receiving a mammogram at four breast centers. Singing River has used Volpara's Risk Pathways cancer risk assessment software to identify patients at elevated risk who are eligible for breast MRI or genetic testing over the past three years.
In late December, Lunit announced it planned to acquire Volpara. Volpara announced the plan as a Scheme Implementation Agreement which is expected to be completed by Q2 2024, although Volpara can sell Lunit’s products immediately.
